Filgotinib-d4 – 1 mg

Brand:
Cayman
CAS:
2041095-50-3
Storage:
-20
UN-No:
Non-Hazardous - /

Filgotinib-d4 is intended for use as an internal standard for the quantification of filgotinib (Item No. 17669) by GC- or LC-MS. Filgotinib is a JAK1 inhibitor (IC50 = 10 nM).{30750} It is selective for JAK1 over JAK3 (IC50 = 810 nM) but also inhibits JAK2 and tyrosine kinase 2 (Tyk2; IC50s = 28 and 116 nM, respectively), as well as Abl, FLT1, -3 and -4, FMS, Mer, and TBK1 activity by greater than 35% in a panel of 177 tyrosine kinases at 1 µM. Filgotinib inhibits IL-6-induced phosphorylation of STAT1 in CD4+ T cells with an IC50 value of 629 nM in isolated human whole blood. It reduces hind paw macrophage and T cell infiltration and bone erosion in a rat model of collagen-induced arthritis when administered at doses ranging from 0.1 to 30 mg/kg per day for 15 days.  

 

Available on backorder

SKU: 28875 - 1 mg Category:

Description

An internal standard for the quantification of filgotinib by GC- or LC-MS


Formal name: N-[5-[4-[(1,1-dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropane-2,2,3,3-d4-carboxamide

Synonyms:  GLPG0634-d4

Molecular weight: 429.5

CAS: 2041095-50-3

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A solid